ShawnL.SearleMD

Family Medicine • Salt Lake City, UT

Addiction Medicine

Principal Investigator

Join to view full profile

Dr. Searle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Searle's full profile

Already have an account?

Office
3838 S 700 E
Suite 202
Salt Lake City, UT 84106
Phone+1 801-269-8200

Education & Training

University of Arizona College of Medicine-PhoenixResidency, Family Medicine, 1996 - 1999
The University of Texas Health Science Center at San AntonioClass of 1996

Certifications & Licensure

UT State Medical License 2013 - 2026
NV State Medical License 2024 - 2025
AZ State Medical License 1997 - 2018
WA State Medical License 2011 - 2014
American Board of Family Medicine Family Medicine

Clinical Trials

Safety Study of Topical Human FGF-1 for Wound Healing Start of enrollment: 2012 Nov 01
Unknown status
Phase 1
Omnitram Pharmacokinetic Study In Healthy Volunteers Start of enrollment: 2014 Aug 01
Completed
Phase 1
A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia Start of enrollment: 2016 Mar 01
Completed
Phase 1
Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers Start of enrollment: 2017 Oct 31
Completed
Phase 1
Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users Start of enrollment: 2015 Jun 23
Completed
Phase 1
Absolute Oral Bioavailability of Remimazolam Start of enrollment: 2015 Nov 03
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

69 citations
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study.
Marja K. Puurunen, Jerry Vockley, Shawn Searle, Stephanie Sacharow, John A. Phillips
Nature Metabolism. 2021-07-22
20 citations
Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers a...
Jason M. Gow, Wayne Tsuji, Gary J. Williams, Daniel T. Mytych, David Sciberras
Arthritis Research & Therapy. 2015-10-08
4 citations
Mass balance, routes of excretion, and pharmacokinetics of investigational oral [14C]-alisertib (MLN8237), an Aurora A kinase inhibitor in patients with advanced solid...
Xiaofei Zhou, Sandeepraj Pusalkar, Swapan Chowdhury, Shawn Searle, Yuexian Li
Investigational New Drugs. 2019-08-01